667, L.P. sells TARA common stock in brokered trades

667, L.P. reported sales of Common Stock for TARA.

Rhea-AI Filing Summary

667, L.P. reported sales of Common Stock for TARA. The filing shows sales of 26,755 shares on 02/24/2026 for $161,584.00 and 78,716 shares on 02/25/2026 for $457,046.00.

The transactions are listed through a broker (Canaccord Genuity LLC) on 03/04/2026.

Insights

Securities Compliance Analyst

Reported brokered sales by an affiliate are routine disclosure of insider transactions.

The record lists two specific sales by 667, L.P.: $161,584.00 for 26,755 shares on 02/24/2026 and $457,046.00 for 78,716 shares on 02/25/2026.

These entries identify the executing broker as Canaccord Genuity LLC and show the broker filing date as 03/04/2026

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who sold shares in the TARA Form 144 filing?

The filing shows sales by 667, L.P.. It lists a sale of 26,755 shares on 02/24/2026 and 78,716 shares on 02/25/2026, each with the reported aggregate dollar amounts.

What broker handled the transactions reported in TARA Form 144?

The reported broker is Canaccord Genuity LLC. The filing references the broker's address and lists the broker-related entries with a broker filing date of 03/04/2026 aligned to the reported transactions.

What were the dollar proceeds reported for the TARA sales?

The filing shows aggregate proceeds of $161,584.00 for the 26,755-share sale on 02/24/2026 and $457,046.00 for the 78,716-share sale on 02/25/2026 as listed in the entries.

When were the TARA transactions executed and filed?

The sales are dated 02/24/2026 and 02/25/2026 in the record, with the broker-related filing entries showing 03/04/2026 as the associated filing/broker date in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/04/2026 - 08:37 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001551139
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Protara Therapeutics, Inc.
SEC File Number	001-36694
Address of Issuer	345 Park Avenue South Third Floor New York NEW YORK 10010
Phone	646-844-0337
Name of Person for Whose Account the Securities are To Be Sold	667, L.P.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Canaccord Genuity LLC 99 High Street, Suite 1200 Boston MA 02110	35173	220151.00	53587260	03/04/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/04/2026	See Remark 2	Broker			35173	03/04/2026	See Remark 2

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
667, L.P. 860 Washington Street, 3rd Floor New York NY 10014	Common Stock	02/24/2026	26755	161584.00
667, L.P. 860 Washington Street, 3rd Floor New York NY 10014	Common Stock	02/25/2026	78716	457046.00

144: Remarks and Signature

Remarks	(1) 667, L.P. is affiliated with Baker Brothers Life Sciences, L.P. Baker Bros. Advisors LP serves as the investment adviser to 667, L.P. and Baker Brothers Life Sciences, L.P. Baker Brothers Life Sciences, L.P. is filing separately for the sale of 424,125 shares of common stock ("Common Stock") of Protara Therapeutics, Inc. (the "Issuer"), which along with the reported sales in this form by 667, L.P. totals 459,298 shares of Common Stock. (2) Common Stock borrowed from broker.
Date of Notice	03/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	By: BAKER BROS. ADVISORS LP, mgmt company and IA to 667, L.P., /s/ Scott L. Lessing, President
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)